We are excited to announce the launch of new products from the combined PerkinElmer-Cisbio reagent portfolio.
Using the HTRF® technology:
1 assay for the detection of human & mouse TAR DNA binding protein 43 (TDP-43), a nucleic acid binding protein involved in RNA-related metabolism which aggregation is involved in neurodegenerative diseases.
• TDP-43 aggregation Kit
1 binding kit to identify inhibitors of cytokine/cytokine receptor interaction.
• Human IL17A/IL17RA binding kit
2 kits for the detection of MDA-5, an RIG-I-like receptor that acts as a cytoplasmic sensor of double stranded RNA, and plays a major role in sensing viral infection and in the activation of a cascade of antiviral responses including the induction of type I interferons and proinflammatory cytokines..
• MDA5 aggregation kit
• MDA5 kit
Using the AlphaLISA® Surefire® UltraTM technology:
Using the AlphaLISA® technology:
For all the Alpha® products, please contact your local representatives or visit www.perkinelmer.com.